Navigation Links
MyMedLab Releases First Offer in Its Unique Personalized Medicine Series
Date:8/10/2009

The first program launched is with thyroid patient advocate and best selling author Mary Shomon

Joplin, MO (PRWEB) August 10, 2009 -- MyMedLab, Inc. today announced the first in a series of collaborations with best-selling authors and health leaders in their "Personalized Medicine" series. The author chosen to pilot the first release is nationally-known thyroid patient advocate and best-selling author Mary Shomon. The new program creates an offer that combines a copy of Mary Shomon's new book The Menopause Thyroid Solution, a custom MyMedLab test panel created by Shomon to complement her book, and a personal coaching consultation with Mary to discuss a plan of action.

"We are very excited to have Mary and her new book be a part of this next generation health care solution", says David Clymer, MyMedLab CEO. "There are a number of reasons why the author and the subject of thyroid health is a great fit for personalized medicine. Thyroid problems are not difficult to diagnose with the correct lab tests, but they continue to be among the most under-diagnosed and overlooked conditions for women in America," explains Clymer.

Individuals researching and advocating for their health frequently encounter a whole host of adversarial points of view. Doctors may be following conventional approaches that are more about masking symptoms than finding and treating the cause. Managed care environments may be attempting to limit access to the more advanced tests, as a way to contain costs. And the shear number of solutions available, both online and in print, often leave the consumer with more questions than answers.

The goal of the "Personalized Medicine" series is put all this information together and speak to the consumer in one voice. The result is the potential is to spark a national conversation and transform an author's book into a health care manual. Initial lab tests, available directly to the consumer at over 2000 locations nationwide, create a starting point or health "baselines" that are unique to them. Once armed with their health information, they work directly with the author to chart their course. Then 60-90 days later they can retest only problem areas to see improvement and track changes in their health over time.

"I became an advocate for thyroid patients out of necessity," says author Mary Shomon. "My own struggle with thyroid problems has fueled my lifelong quest to provide real answers to people in need. The first step involves translating complicated medical information into plain language that everyone can understand. Once they understand the problem, the science of testing is the logical next step. I was thrilled at the chance to work with MyMedLab to help empower thyroid patients in this exciting new way."

Says Shomon, "Many women in their 40s and 50s are unable to determine if common symptoms like fatigue, menstrual irregularities, sleep disturbances, low libido, moodiness and weight gain are the result of a thyroid problems, perimenopause, or both. Now, in one step, they can order a copy of Menopause Thyroid Solution, get a lab order for a series of critical tests, and connect with me by phone to talk about their options, and find the right doctors. It's a phenomenal opportunity for women to take charge of their own health in a way that has never been done before!"

MyMedLab is already partnering with other authors to expand the series to other health conditions like Bio-identical hormones, Celiac Disease, Fibromyalgia and Fatigue. They have also provided a way for the public to suggest future offers and nominate their favorite author at next.author@mymedlab.com "We are always amazed at the great ideas our customers have when you let them get involved in the process. Most are eager to share their positive experiences with others and help them avoid the pitfalls that slowed their own progress." say Clymer.

About MyMedLab. - MyMedLab is a privately held company with the primary mission of empowering consumers to make informed health care choices. As a leading provider of direct-to-consumer (DTC) laboratory testing services, MyMedLab has developed a unique suite of software applications and professional networks that enable the ordering, processing, and reporting of test results directly to consumers. This innovative set of services includes access to wellness tests organized by organ and disease profiles, physician oversight of test ordering, educational laboratory content, and results reporting through the web-based platform. For additional information, please see www.mymedlab.com.

###

Read the full story at http://www.prweb.com/releases/personalized/medicine/prweb2732224.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. APA Releases Report on Sexuality Debate
2. ORTHOWORLD Releases Position Paper on Healthcare Reform
3. PracticeMatch Releases Results of Recent State of the Industry Survey of Physician Recruiters
4. Census Bureau Releases Comprehensive Health Insurance Coverage Estimates by County
5. Concord Coalition Releases Issue Brief on Administrations IMAC Proposal
6. Insurance Department Releases Report on Executive Compensation at States Largest Blues Plans
7. Photos: Compete Releases Top Insurance and Physician Web Sites for June 2009
8. NBCH Releases Report on Health Plans Performance for Cardiovascular Disease Care and Prevention
9. Integrated Healthcare Association Releases White Paper on Pay for Performance
10. Wonderbox Technologies(R) Releases Version 4.5 of the Enterprise System
11. Shelbourne Releases New Information on Knee Replacement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... ... Buyers and sellers in the thriving multi-billion dollar cannabis marketplace – from ... be heartened by the industry’s current surge. But another thing that unifies them is ... At last they can simply, safely and effectively end their aroma anguish thanks to ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol ... is introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex ... in horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the ...
(Date:4/24/2017)... ... April 24, 2017 , ... The Santana Telehealth Project was ... Telehealth 2.0 — the American Telemedicine Association’s annual conference, on April 23 in Orlando, ... using telemedicine to improve the lives of the poor and underserved in other parts ...
(Date:4/24/2017)... ... 24, 2017 , ... Today, Bright Pink , a national non-profit organization focusing on the ... CEO. , Bright Pink is proud to announce Katie Thiede as their new Chief ... new role as Chairman of the Board and launched a national search to find ...
(Date:4/24/2017)... Raton, Florida (PRWEB) , ... April 24, 2017 ... ... develops a variety of unique liquid food supplements, announced its popular products are ... nutritional products. , ALP Nutrition® prioritizes the use of premium natural ingredients ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 Global Surgical ... devices are tubes used to remove excess liquid and ... serum, pus, urine, bile or lymph. Surgical drains are ... surgery such as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic ... prophylactic post-surgery to prevent accumulation of fluid e.g. blood ...
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
(Date:4/18/2017)... Cogentix Medical, Inc. (NASDAQ: CGNT), a global ... and Gynecology markets with innovative and proprietary products, will ... 31, 2017 after the market close on Tuesday, May ... a conference call and webcast to discuss its financial ... at 4:30 p.m. Eastern Time (3:30 p.m. Central Time). ...
Breaking Medicine Technology: